References
- Kochanek M, Schalk E, von Bergwelt-Baildon M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2019;98(5):1051–1069.
- Vembadi A, Menachery A, Qasaimeh MA. Cell cytometry: review and perspective on biotechnological advances. Front Bioeng Biotechnol. 2019;7:147.
- Ben-Yosef Y, Marom B, Hirshberg G, et al. The HemoScreen, a novel haematology analyser for the point of care. J Clin Pathol. 2016;69(8):720–725.
- Kur DK, Agersnap N, Holländer NH, et al. Evaluation of the HemoCue WBC DIFF in leukopenic patient samples. Int J Lab Hematol. 2020;42(3):256–262.
- Åsberg A, Løfblad L, Felic A, et al. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay. Scand J Clin Lab Invest. 2019;79(1-2):50–57.
- Koczula KM, Gallotta A. Lateral flow assays. Essays Biochem. 2016;60(1):111–120.
- Ting-Beall HP, Needham D, Hochmuth RM. Volume and osmotic properties of human neutrophils. Blood. 1993;81(10):2774–2780.
- Royston P, Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology–with an emphasis on fractional polynomials. Methods Inf Med. 2005;44(04):561–571.
- Fagerhol MK, Nielsen HG, Vetlesen A, et al. Increase in plasma calprotectin during long-distance running. Scand J Clin Lab Invest. 2005;65(3):211–220.